Ligand Pharmaceuticals reported $786.52M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Acorda Therapeutics ACOR:US $ 190.48M 15.8M
Agenus AGEN:US $ -228.84M 61.78M
Amgen AMGN:US $ 8247M 1087M
Anika Therapeutics ANIK:US $ 286.8M 10.15M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Arrowhead Research ARWR:US $ 436.89M 8.66M
Baxter International BAX:US $ 8494M 42M
Bristol Myers Squibb BMY:US $ 36808M 797M
Clovis Oncology CLVS:US $ -206.98M 14.06M
Dicerna Pharmaceuticals DRNA:US $ 111.07M 15.33M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Enanta Pharmaceuticals ENTA:US $ 417.85M 18.18M
Endo International Ordinary Shares ENDP:US $ -617.04M 18.07M
Flexion Therapeutics FLXN:US $ -56171000 17.3M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Glaxosmithkline GSK:US $ 15377M 512M
Harsco HSC:US $ 693.5M 33.53M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Immunogen IMGN:US $ 68.46M 25.66M
Insmed INSM:US $ 531.05M 329.42M
Intrexon XON:US $ 159.2M 15.6M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Lannett LCI:US $ -27.47M 151.52M
Ligand Pharmaceuticals LGND:US $ 786.52M 40.68M
Macrogenics MGNX:US $ 319.04M 31.49M
Pacira Pharmaceuticals PCRX:US $ 687.17M 36.35M
Rigel Pharmaceuticals RIGL:US $ 68.11M 10.19M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Spectrum Pharmaceuticals SPPI:US $ 108.59M 13.85M
Teva Pharmaceutical Industries TEVA:US $ 10324M 324M
Veracyte VCYT:US $ 971.18M 3.05M